Covid-19 Research

Review Article

FAM40A Deficiency Activates the Hippo Pathway to Promote Podocyte Apoptosis and Contribute to FSGS

Journal of Biomedical Research & Environmental Sciences article abstract with citation details, DOI, publication dates, subject areas, full text links, and references.

View DOI Submit Manuscript

Article Details

Publication record, authors, dates, abstract, and full text access.

Open Access
Article Type Review Article
Subject Medicine Group
OCLC JBRES Record
Chen Z and Guo Z
Issue: Volume6-Issue12
Pages: 1911-1928
Received: 2025-12-05
Accepted: 2025-12-15
Published: 2025-12-16

Abstract

Background: Focal Segmental Glomerulosclerosis (FSGS), a major cause of end-stage renal disease, is characterized by podocyte loss via apoptosis and cytoskeletal disruption. Although dysregulation of the Hippo-YAP pathway is implicated in podocyte injury, upstream regulators of this pathway in FSGS pathogenesis remain elusive.
Methods: To determine whether FAM40A deficiency precipitates FSGS, we generated heterozygous FAM40A+/− mice by CRISPR/Cas9-mediated deletion of exons 3-8 (Δex3-8 allele). At specified time points, kidneys were collected for histological examination (PAS, TEM), immunofluorescence, and Western blotting to quantify podocyte apoptosis and Hippo pathway activation. Finally, FAM40A+/− mice were randomly assigned to receive treatment with the MST1/2 inhibitor XMU-MP-1 (1 mg/kg/day) via intraperitoneal injection or vehicle treatment for 10 days. Endpoints included urinary Albumin-to-Creatinine Ratio (ACR), renal histology, podocyte density, and podocyte apoptosis markers.
Results: We identified FAM40A as a novel negative regulator of the Hippo pathway in podocytes. FAM40A directly suppressed the kinase activity of Mst1/2, thereby preventing phosphorylation and inactivation of the downstream effector YAP. FAM40A deficiency triggered Mst1/2 activation, leading to YAP phosphorylation, nuclear exclusion, and transcriptional repression. This cascade resulted in podocyte apoptosis and exacerbated FSGS phenotypes In vivo.
Conclusion: Our study defines the FAM40A-Mst1/2-YAP axis as a critical signalling pathway governing podocyte survival. Loss of FAM40A activates Hippo signalling to promote podocyte apoptosis and FSGS progression. While short-term MST1/2 inhibition ameliorates disease features in mice, further evaluation of safety and feasibility is required. These findings highlight FAM40A as a potential therapeutic target for FSGS.

FullText HTML FullText PDF DOI: 10.37871/jbres2240 Crossmark

Certificate of Publication

Certificate of Publication

Copyright

© 2025 Chen Z, et al. Distributed under Creative Commons CC-BY 4.0 Creative CommonsAttribution

How to cite this article

Chen Z, Guo Z. FAM40A Defi ciency Activates the Hippo Pathway to Promote Podocyte Apoptosis and Contribute to FSGS. J Biomed Res Environ Sci. 2025 Dec 16; 6(12): 1911-1928. doi: 10.37871/jbres2240, Article ID: JBRES2240, Available at: https://www.jelsciences.com/articles/jbres2240.pdf

Subject area(s)

PathologyNephrology

References

  1. Altintas MM, Agarwal S, Sudhini Y, Zhu K, Wei C, Reiser J. Pathogenesis of Focal Segmental Glomerulosclerosis and Related Disorders. Annu Rev Pathol. 2025 Jan;20(1):329-353. doi: 10.1146/annurev-pathol-051220-092001. PMID: 39854184; PMCID: PMC11875227.
  2. Suresh V, Stillman IE, Campbell KN, Meliambro K. Focal Segmental Glomerulosclerosis. Adv Kidney Dis Health. 2024 Jul;31(4):275-289. doi: 10.1053/j.akdh.2024.03.009. PMID: 39084753.
  3. Rosenberg AZ, Kopp JB. Focal Segmental Glomerulosclerosis. Clin J Am Soc Nephrol. 2017 Mar 7;12(3):502-517. doi: 10.2215/CJN.05960616. Epub 2017 Feb 27. Erratum in: Clin J Am Soc Nephrol. 2018 Dec 7;13(12):1889. doi: 10.2215/CJN.12071018. PMID: 28242845; PMCID: PMC5338705.
  4. Sadowski CE, Lovric S, Ashraf S, Pabst WL, Gee HY, Kohl S, Engelmann S, Vega-Warner V, Fang H, Halbritter J, Somers MJ, Tan W, Shril S, Fessi I, Lifton RP, Bockenhauer D, El-Desoky S, Kari JA, Zenker M, Kemper MJ, Mueller D, Fathy HM, Soliman NA; SRNS Study Group; Hildebrandt F. A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome. J Am Soc Nephrol. 2015 Jun;26(6):1279-89. doi: 10.1681/ASN.2014050489. Epub 2014 Oct 27. PMID: 25349199; PMCID: PMC4446877.
  5. Chen Z, Zhang Y, Zhao X. FAM40A alters the cytoskeleton of podocytes in familial focal and segmental glomerulosclerosis by regulating F-actin and nephrin. Arch Med Sci. 2019 Jan;15(1):165-173. doi: 10.5114/aoms.2018.73138. Epub 2018 Feb 2. PMID: 30697267; PMCID: PMC6348344.
  6. Madsen CD, Hooper S, Tozluoglu M, Bruckbauer A, Fletcher G, Erler JT, Bates PA, Thompson B, Sahai E. STRIPAK components determine mode of cancer cell migration and metastasis. Nat Cell Biol. 2015 Jan;17(1):68-80. doi: 10.1038/ncb3083. Epub 2014 Dec 22. PMID: 25531779; PMCID: PMC5354264.
  7. Bai SW, Herrera-Abreu MT, Rohn JL, Racine V, Tajadura V, Suryavanshi N, Bechtel S, Wiemann S, Baum B, Ridley AJ. Identification and characterization of a set of conserved and new regulators of cytoskeletal organization, cell morphology and migration. BMC Biol. 2011 Aug 11;9:54. doi: 10.1186/1741-7007-9-54. Erratum in: BMC Biol. 2024 Oct 10;22(1):228. doi: 10.1186/s12915-024-02036-3. PMID: 21834987; PMCID: PMC3201212.
  8. Tang Y, Chen M, Zhou L, Ma J, Li Y, Zhang H, Shi Z, Xu Q, Zhang X, Gao Z, Zhao Y, Cheng Y, Jiao S, Zhou Z. Architecture, substructures, and dynamic assembly of STRIPAK complexes in Hippo signaling. Cell Discov. 2019 Jan 8;5:3. doi: 10.1038/s41421-018-0077-3. PMID: 30622739; PMCID: PMC6323126.
  9. Hwang J, Pallas DC. STRIPAK complexes: structure, biological function, and involvement in human diseases. Int J Biochem Cell Biol. 2014 Feb;47:118-48. doi: 10.1016/j.biocel.2013.11.021. Epub 2013 Dec 11. PMID: 24333164; PMCID: PMC3927685.
  10. Chen R, Xie R, Meng Z, Ma S, Guan KL. STRIPAK integrates upstream signals to initiate the Hippo kinase cascade. Nat Cell Biol. 2019 Dec;21(12):1565-1577. doi: 10.1038/s41556-019-0426-y. Epub 2019 Dec 2. Erratum in: Nat Cell Biol. 2020 Feb;22(2):257. doi: 10.1038/s41556-019-0460-9. PMID: 31792377.
  11. Zhuang Q, Li F, Liu J, Wang H, Tian Y, Zhang Z, Wang F, Zhao Z, Chen J, Wu H. Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis. Lab Invest. 2021 Feb;101(2):258-270. doi: 10.1038/s41374-020-00503-3. Epub 2020 Nov 17. PMID: 33203894; PMCID: PMC7815513.
  12. Gilhaus K, Cepok C, Kamm D, Surmann B, Nedvetsky PI, Emich J, Sundukova A, Saatkamp K, Nüsse H, Klingauf J, Wennmann DO, George B, Krahn MP, Pavenstädt HJ, Vollenbröker BA. Activation of Hippo Pathway Damages Slit Diaphragm by Deprivation of Ajuba Proteins. J Am Soc Nephrol. 2023 Jun 1;34(6):1039-1055. doi: 10.1681/ASN.0000000000000107. Epub 2023 Mar 16. PMID: 36930055; PMCID: PMC10278832.
  13. Ester L, Cabrita I, Ventzke M, Kieckhöfer E, Christodoulou M, Mandel AM, Diefenhardt P, Fabretti F, Benzing T, Habbig S, Schermer B. The role of the FSGS disease gene product and nuclear pore protein NUP205 in regulating nuclear localization and activity of transcriptional regulators YAP and TAZ. Hum Mol Genet. 2023 Nov 3;32(22):3153-3165. doi: 10.1093/hmg/ddad135. PMID: 37565816; PMCID: PMC10630254.
  14. Zhang N, Shen X, Yu Y, Xu L, Wang Z, Zhu J. Lead exposure promotes NF2-wildtype meningioma cell proliferation through the Merlin-Hippo signaling pathway. Environ Health Prev Med. 2025;30:8. doi: 10.1265/ehpm.24-00216. PMID: 39894505; PMCID: PMC11790403.
  15. Ma S, Meng Z, Chen R, Guan KL. The Hippo Pathway: Biology and Pathophysiology. Annu Rev Biochem. 2019 Jun 20;88:577-604. doi: 10.1146/annurev-biochem-013118-111829. Epub 2019 Dec 19. PMID: 30566373.
  16. Erekat NS. Apoptosis and its role in renal diseases. In cell death - aAutophagy, apoptosis and necrosis. Intechopen.
  17. Bazzi H, Soroka E, Alcorn HL, Anderson KV. STRIP1, a core component of STRIPAK complexes, is essential for normal mesoderm migration in the mouse embryo. Proc Natl Acad Sci U S A. 2017 Dec 19;114(51):E10928-E10936. doi: 10.1073/pnas.1713535114. Epub 2017 Dec 4. PMID: 29203676; PMCID: PMC5754794.
  18. Moya IM, Halder G. Hippo-YAP/TAZ signalling in organ regeneration and regenerative medicine. Nat Rev Mol Cell Biol. 2019 Apr;20(4):211-226. doi: 10.1038/s41580-018-0086-y. PMID: 30546055.
  19. Bonse J, Wennmann DO, Kremerskothen J, Weide T, Michgehl U, Pavenstädt H, Vollenbröker B. Nuclear YAP localization as a key regulator of podocyte function. Cell Death Dis. 2018 Aug 28;9(9):850. doi: 10.1038/s41419-018-0878-1. PMID: 30154411; PMCID: PMC6113334.
  20. Wennmann DO, Vollenbröker B, Eckart AK, Bonse J, Erdmann F, Wolters DA, Schenk LK, Schulze U, Kremerskothen J, Weide T, Pavenstädt H. The Hippo pathway is controlled by Angiotensin II signaling and its reactivation induces apoptosis in podocytes. Cell Death Dis. 2014 Nov 13;5(11):e1519. doi: 10.1038/cddis.2014.476. PMID: 25393475; PMCID: PMC4260734.
  21. Schwartzman M, Reginensi A, Wong JS, Basgen JM, Meliambro K, Nicholas SB, D'Agati V, McNeill H, Campbell KN. Podocyte-Specific Deletion of Yes-Associated Protein Causes FSGS and Progressive Renal Failure. J Am Soc Nephrol. 2016 Jan;27(1):216-26. doi: 10.1681/ASN.2014090916. Epub 2015 May 26. PMID: 26015453; PMCID: PMC4696566.
  22. Meliambro K, Wong JS, Ray J, Calizo RC, Towne S, Cole B, El Salem F, Gordon RE, Kaufman L, He JC, Azeloglu EU, Campbell KN. The Hippo pathway regulator KIBRA promotes podocyte injury by inhibiting YAP signaling and disrupting actin cytoskeletal dynamics. J Biol Chem. 2017 Dec 22;292(51):21137-21148. doi: 10.1074/jbc.M117.819029. Epub 2017 Oct 5. PMID: 28982981; PMCID: PMC5743086.
  23. Fu J, Guan KL. The hippo signalling pathway and its implications in kidney homeostasis and disease. Nature reviews. Nephrology.2023;19(10):672-684.
  24. Zhuang Q, Li F, Liu J, Wang H, Tian Y, Zhang Z, Wang F, Zhao Z, Chen J, Wu H. Nuclear exclusion of YAP exacerbates podocyte apoptosis and disease progression in Adriamycin-induced focal segmental glomerulosclerosis. Lab Invest. 2021 Feb;101(2):258-270. doi: 10.1038/s41374-020-00503-3. Epub 2020 Nov 17. PMID: 33203894; PMCID: PMC7815513.
  25. Shao G, Xu J, Hu C, Jia W, Xu X, Gu Y, Zhang L, Zheng Z, Zhong J, Zhu S, Meng S, Zhao Z, Zhang Z, Liu J, Xu Y, Wu H. Podocyte YAP ablation decreases podocyte adhesion and exacerbates FSGS progression through α3β1 integrin. J Pathol. 2025 Jan;265(1):84-98. doi: 10.1002/path.6370. PMID: 39668547.
  26. Kato K, Maehama T. The role of YAP/TAZ in integrin-mediated mechanotransduction. Journal of cell science. 2024;137(5): 261545.
  27. Vollenbröker B, George B, Wolfgart M, Saleem M A, Pavenstädt H, Weide T. The Hippo pathway in kidney diseases. Cellular signalling. 2019;65:109420.
Publish with JBRES — Peer-reviewed, multidisciplinary Open Access with rapid review, DOI, and global visibility.
Double-Blind CrossRef DOI Discoverable
Submit Manuscript Membership